109 related articles for article (PubMed ID: 16282852)
1. The prevalence of hyperprolactinemia after long-term haloperidol use in patients with chronic schizophrenia.
Jung DU; Seo YS; Park JH; Jeong CY; Conley RR; Kelly DL; Shim JC
J Clin Psychopharmacol; 2005 Dec; 25(6):613-5. PubMed ID: 16282852
[No Abstract] [Full Text] [Related]
2. Prevalence of hyperprolactinemia in schizophrenia: association with typical and atypical antipsychotic treatment.
Montgomery J; Winterbottom E; Jessani M; Kohegyi E; Fulmer J; Seamonds B; Josiassen RC
J Clin Psychiatry; 2004 Nov; 65(11):1491-8. PubMed ID: 15554761
[TBL] [Abstract][Full Text] [Related]
3. Significant elevations of prolactin levels in patients who shifted from conventional depot antipsychotics to long-acting risperidone.
Lai YC; Chiou CC; Chen CH; Huang MC
J Clin Psychopharmacol; 2007 Oct; 27(5):523-4. PubMed ID: 17873693
[No Abstract] [Full Text] [Related]
4. Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study.
Byerly MJ; Marcus RN; Tran QV; Eudicone JM; Whitehead R; Baker RA
Schizophr Res; 2009 Feb; 107(2-3):218-22. PubMed ID: 19038534
[TBL] [Abstract][Full Text] [Related]
5. [Prolactinemia and predictability of therapeutic response of schizophrenic patients in acute decompensation].
Vanelle JM; Amorim P; Piketti ML; Bourdel MC; Poirier-Littré MF
Encephale; 1996 Oct; 22 Spec No 3():82-4. PubMed ID: 8954284
[No Abstract] [Full Text] [Related]
6. Failure of pyridoxine to effect neuroleptic-induced hyperprolactinemia in psychotic patients.
Brambilla F; Penati G; Freni S; Bottinelli S; Maffei C; Maiella V
J Endocrinol Invest; 1979; 2(3):299-302. PubMed ID: 43342
[TBL] [Abstract][Full Text] [Related]
7. Relationship between prolactin levels and subjective endocrine-related adverse effects in patients with schizophrenia receiving long-term treatment with amisulpride.
Kim EY; Kim SH; Lee NY; Jung DC; Kim YS; Ahn YM
Pharmacopsychiatry; 2012 Mar; 45(2):57-63. PubMed ID: 22411694
[TBL] [Abstract][Full Text] [Related]
8. Partial regimen replacement with aripiprazole reduces serum prolactin in patients with a long history of schizophrenia: A case series.
Naono-Nagatomo K; Naono H; Abe H; Takeda R; Funahashi H; Uchimura D; Ishida Y
Asian J Psychiatr; 2017 Feb; 25():36-41. PubMed ID: 28262171
[TBL] [Abstract][Full Text] [Related]
9. Tolerance to prolactin secretion in the long-term treatment with neuroleptics in schizophrenia.
Igarashi Y; Higuchi T; Toyoshima R; Noguchi T; Moroji T
Adv Biochem Psychopharmacol; 1985; 40():95-8. PubMed ID: 2862770
[No Abstract] [Full Text] [Related]
10. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
Arakawa R; Okumura M; Ito H; Takano A; Takahashi H; Takano H; Maeda J; Okubo Y; Suhara T
J Clin Psychiatry; 2010 Sep; 71(9):1131-7. PubMed ID: 20361897
[TBL] [Abstract][Full Text] [Related]
11. Prolactin levels and effects of neuroleptics.
Brown WA
Psychosomatics; 1983 Jun; 24(6):569-74, 577-81. PubMed ID: 6136065
[No Abstract] [Full Text] [Related]
12. The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia.
David SR; Taylor CC; Kinon BJ; Breier A
Clin Ther; 2000 Sep; 22(9):1085-96. PubMed ID: 11048906
[TBL] [Abstract][Full Text] [Related]
13. Effect of the addition of aripiprazole on hyperprolactinemia associated with risperidone long-acting injection.
Ziadi Trives M; Bonete Llácer JM; García Escudero MA; Martínez Pastor CJ
J Clin Psychopharmacol; 2013 Aug; 33(4):538-41. PubMed ID: 23775053
[TBL] [Abstract][Full Text] [Related]
14. Resolution of haloperidol-induced hyperprolactinemia with aripiprazole.
Lorenz RA; Weinstein B
J Clin Psychopharmacol; 2007 Oct; 27(5):524-5. PubMed ID: 17873694
[No Abstract] [Full Text] [Related]
15. Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.
Shim JC; Shin JG; Kelly DL; Jung DU; Seo YS; Liu KH; Shon JH; Conley RR
Am J Psychiatry; 2007 Sep; 164(9):1404-10. PubMed ID: 17728426
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment with blonanserin for drug-induced hyperprolactinemia in chronic schizophrenia patients: a six-month follow-up of two cases.
Kito S; Hasegawa T; Nakajima T; Koga Y; Hibi S; Tobe Y; Mochida M
J Neuropsychiatry Clin Neurosci; 2013; 25(3):E29-30. PubMed ID: 24026734
[No Abstract] [Full Text] [Related]
17. Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study.
Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC
Psychopharmacology (Berl); 2005 Feb; 178(1):35-40. PubMed ID: 15289996
[TBL] [Abstract][Full Text] [Related]
18. Switching female schizophrenic patients to quetiapine from conventional antipsychotic drugs: effects on hyperprolactinemia.
Nakajima M; Terao T; Iwata N; Nakamura J
Pharmacopsychiatry; 2005 Jan; 38(1):17-9. PubMed ID: 15706461
[TBL] [Abstract][Full Text] [Related]
19. Association of high prolactin levels and neuroleptics immediately postpartum.
LaFleur P; Van Norman J; Nader S; Shapiro L; Peabody CA
J Neuropsychiatry Clin Neurosci; 1990; 2(1):115. PubMed ID: 2136057
[No Abstract] [Full Text] [Related]
20. Dosing the antipsychotic medication olanzapine.
Nemeroff CB
J Clin Psychiatry; 1997; 58 Suppl 10():45-9. PubMed ID: 9265916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]